Greenwich lifesciences announces addition of austria to FLAMINGO-01 clinical trial
Oct 9 (Reuters) - Greenwich Lifesciences Inc GLSI.O:
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.